Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
H. Bai, E. Lewitus, Y. Li, V. Dussupt, B. Slike, L. Mendez-Rivera, A. Schmid, L. Wieczorek, V. Polonis, S. J. Krebs, J. A. Ake, S. Vasan, M. G. Joyce, S. Townsley, M. Rolland
The paper redesigns hypervariable loops in HIV-1 Env consensus sequences to enhance antibody binding and improve vaccine antigen design.
bioRxiv · Nov 19, 2023 · PreprintMicrobiology
K. M. Wuertz, E. Barkei, W.-h. Chen, E. J. Martinez, I. E. Naouar, L. Jagodzinski, D. Paquin-Proulx, G. D. Gromowski, I. Swafford, A. Ganesh, M. Dong, X. Zeng, P. V. Thomas, R. S. Sankhala, A. Hajduczki, , Vasan
This study evaluates a SARS-CoV-2 spike ferritin nanoparticle vaccine's effectiveness against B.1.1.7 and B.1.351 variants in hamsters, showing protection against disease and viral replication.
bioRxiv · Jun 16, 2021 · PreprintImmunology
H. A. D. King, M. G. Joyce, I. Elakhal Naouar, A. Ahmed, C. Macedo Cincotta, C. Subra, K. K. Peachman, H. H. Hack, R. E. Chen, P. V. Thomas, W.-H. Chen, R. S. Sankhala, A. Hajduczki, E. J. Martinez, C. E. Peterson, , L. L Jagodzinski
This study evaluates an adjuvanted SARS-CoV-2 RBD nanoparticle vaccine in macaques, showing robust immune responses and protection against viral challenge and variants.
bioRxiv · Apr 9, 2021Immunology
M. G. Joyce, H. A. D. King, I. Elakhal Naouar, A. Ahmed, K. K. Peachman, C. M. Cincotta, C. Subra, R. E. Chen, P. V. Thomas, W.-H. Chen, R. S. Sankhala, A. Hajduczki, E. J. Martinez, C. E. Peterson, W. C. Chang, , N. Karasavva
A SARS-CoV-2 Spike ferritin nanoparticle vaccine induces broad neutralizing antibodies and protects nonhuman primates against respiratory infection and disease.
bioRxiv · Mar 24, 2021 · PreprintImmunology
J. A. Gonzalez-Feliciano, P. Y. Akamine, C. M. Capo-Velez, M. Delgado-Velez, V. Dussupt, S. J. Krebs, V. Wojna, V. R. Polonis, A. Baerga-Ortiz, J. A. Lasalde-Dominicci
This paper compares glycosylation and antigenicity of HIV-1 gp145 produced in two cell lines, finding similar antibody recognition despite differences in sialylation.
bioRxiv · Mar 31, 2020Biochemistry